Immediate Impact
2 from Science/Nature 75 standout
Citing Papers
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
2023 Standout
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
2022 Standout
Works of Amir Kashani being referenced
Review of Side-Effect Profile of Combination Ezetimibe and Statin Therapy in Randomized Clinical Trials
2008
Adverse Effects of Combination Angiotensin II Receptor Blockers Plus Angiotensin-Converting Enzyme Inhibitors for Left Ventricular Dysfunction
2007
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Amir Kashani | 553 | 203 | 623 | 42 | 1.4k | |
| Zbigniew Gaciong | 698 | 190 | 487 | 81 | 1.5k | |
| Devaki Nair | 694 | 320 | 458 | 51 | 1.8k | |
| Danilo Menichelli | 204 | 252 | 813 | 68 | 1.7k | |
| Parul Tandon | 409 | 180 | 1391 | 46 | 2.2k | |
| A. Neiß | 333 | 283 | 670 | 41 | 1.4k | |
| N.P. Mallick | 338 | 182 | 230 | 66 | 1.9k | |
| Robert Cramb | 701 | 365 | 316 | 50 | 1.6k | |
| Shu‐Cheng Chen | 207 | 247 | 237 | 37 | 1.5k | |
| J M Thomson | 255 | 124 | 534 | 73 | 1.6k | |
| G. Buccianti | 245 | 198 | 372 | 49 | 1.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...